I don't think the importance of the cash injected from the oppies can be understated aswell. This is so integral to launching the next phase of the business once trials conclude and approvals are in place.
I know a lot of punters have been frustrated with the SP of late but looking to the future the bottom line injection from oppies conversion plays a very important role to what happens post trials and moving forward. This is rare in the small cap space, the usual play in my experience is continual cycles of cap raises and stagnant growth.
IHL Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held